Cipla Launches India’s First Inhalable Insulin, Afrezza
No Comments on Cipla Launches India’s First Inhalable Insulin, Afrezza
January 3, 2025
JNS: Cipla has introduced Afrezza, India’s first inhalable insulin, following approval from the Central Drugs Standard Control Organisation (CDSCO). Developed by MannKind Corporation in the USA, Afrezza offers a needle-free, rapid-acting insulin option…
Swasthmev Launches India’s First Pre-Hospital Emergency Care Centre in Gaya
December 22, 2024
Gaya: Swasthmev inaugurated India’s first Pre-Hospital Emergency Care Centre, Rahat Kendra, in Ranapur, Chakand, Gaya, on Sunday. The center aims to provide critical first aid during the “golden hour” following accidents, particularly on…